Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling

  • Authors:
    • Lu Yang
    • Chaosheng Peng
    • Jing Xia
    • Wenluo Zhang
    • Li Tian
    • Yuhong Tian
    • Xiaobin Yang
    • Yuean Cao
  • View Affiliations

  • Published online on: December 22, 2017     https://doi.org/10.3892/mmr.2017.8342
  • Pages: 4099-4105
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Icariside II is a flavonoid extracted from Epimedium that has antioxidant, anti‑inflammatory and antiapoptotic effects. The aim of the present study was to evaluate the effects icariside II on diabetic cardiomyopathy in streptozotocin-induced diabetic rats. Icariside II treatment improved body weight, heart/body weight ratio and fasting blood glucose in diabetic model rats. Icariside II was demonstrated to reduce the expression levels of creatine kinase and lactate dehydrogenase in serum, and to lower cardiac oxidative stress, inflammation and apoptosis levels in diabetic rats. Icariside II treatment induced phosphoinositide 3‑kinase and phosphorylated‑Akt expression, and suppressed inducible nitric oxide synthase (iNOS) and nuclear factor (NF)‑κB protein expression in diabetic rat. Results from the present study suggested that treatment with icariside II improved diabetic cardiomyopathy in streptozotocin‑induced diabetic rats by activating the Akt/NOS/NF‑κB pathway.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 17 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang L, Peng C, Xia J, Zhang W, Tian L, Tian Y, Yang X and Cao Y: Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling. Mol Med Rep 17: 4099-4105, 2018.
APA
Yang, L., Peng, C., Xia, J., Zhang, W., Tian, L., Tian, Y. ... Cao, Y. (2018). Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling. Molecular Medicine Reports, 17, 4099-4105. https://doi.org/10.3892/mmr.2017.8342
MLA
Yang, L., Peng, C., Xia, J., Zhang, W., Tian, L., Tian, Y., Yang, X., Cao, Y."Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling". Molecular Medicine Reports 17.3 (2018): 4099-4105.
Chicago
Yang, L., Peng, C., Xia, J., Zhang, W., Tian, L., Tian, Y., Yang, X., Cao, Y."Effects of icariside II ameliorates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by activating Akt/NOS/NF-κB signaling". Molecular Medicine Reports 17, no. 3 (2018): 4099-4105. https://doi.org/10.3892/mmr.2017.8342